First-mover API manufacturer in EU-GMP facility, poised to lead the Italian market!

First mover to bring standardized cannabinoid APIs based on phyto-complex to the Italian market

Company is operational, pre-revenue, focused exclusively on cannabis extraction and natural cannabinoids API formulation

Currently undertaking a strategic regulatory path with incremental licensing stages allowing product to market along the way (achieved first milestone as an API distributor)

Ready to offer a range of products and services related to cannabis and its preparation, in order to facilitate patient access to this therapy

Built a 200 sq m cutting-edge pharmaceutical production facility and quality control laboratory

Facility is comprised of cleanroom and essential technical utilities featuring pressure, temperature, and humidity monitoring, a finishing laboratory with controlled contamination, and a laboratory equipped for internal quality control

Experienced, specialized team with robust scientific network and extensive regulatory knowledge

Strong industrial and medical partnerships, along with direct sales, contribute to increased competitiveness in the market

There is a demand for medical cannabis in Italy, but the market lacks specialized companies experienced in navigating regulatory complexities and providing APIs tailored to specific therapeutic needs and clinical trials.

Potential opportunity to introduce medical cannabis flowers and oils in the complex Italian cannabis market

Actively seeking an equity partner to strategically develop high-quality medicinal cannabis product portfolio and further development of its production facility